Rare Tumors (Jun 2023)

Breakthrough treatment choice for Acute Myeloid Leukemia in pediatric and adult patients: Revumenib, an oral selective inhibitor of KMTA2Ar

Areeba Fareed,
Nimrah Inam,
Fatima Faraz

Affiliations

Areeba Fareed
Nimrah Inam
Fatima Faraz

DOI: https://doi.org/10.1177/20363613231183785
Journal volume & issue: Vol. 15

Abstract

No abstracts available.

Published in Rare Tumors

ISSN: 2036-3605 (Print); 2036-3613 (Online)
Publisher: SAGE Publishing
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://journals.sagepub.com/home/rtu

About the journal